PARK15/FBXO7 is dispensable for PINK1/Parkin mitophagy in iNeurons and HeLa cell systems

被引:9
|
作者
Kraus, Felix [1 ]
Goodall, Ellen A. [1 ,2 ]
Smith, Ian R. [1 ]
Jiang, Yizhi [1 ]
Paoli, Julia C. [1 ]
Adolf, Frank [2 ,3 ]
Zhang, Jiuchun [1 ]
Paulo, Joao A. [1 ]
Schulman, Brenda A. [2 ,3 ]
Harper, J. Wade [1 ,2 ]
机构
[1] Harvard Med Sch, Blavatnik Inst, Dept Cell Biol, Boston, MA 02115 USA
[2] Aligning Sci Parkinsons ASAP Collaborat Res Networ, Chevy Chase, MD 20815 USA
[3] Max Planck Inst Biochem, Dept Mol Machines & Signaling, Martinsried, Germany
关键词
FBXO7; iNeurons; mitophagy; proteomics; ubiquitin ligase; FALSE DISCOVERY RATE; PROTEASOME ACTIVITY; UBIQUITIN CHAIN; QUALITY-CONTROL; PARKIN; PINK1; FBXO7; PHOSPHORYLATION; MECHANISM; PLATFORM;
D O I
10.15252/embr.202256399
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The protein kinase PINK1 and ubiquitin ligase Parkin promote removal of damaged mitochondria via a feed-forward mechanism involving ubiquitin (Ub) phosphorylation (pUb), Parkin activation, and ubiquitylation of mitochondrial outer membrane proteins to support the recruitment of mitophagy receptors. The ubiquitin ligase substrate receptor FBXO7/PARK15 is mutated in an early-onset parkinsonian-pyramidal syndrome. Previous studies have proposed a role for FBXO7 in promoting Parkin-dependent mitophagy. Here, we systematically examine the involvement of FBXO7 in depolarization and (UPR)-U-mt-dependent mitophagy in the well-established HeLa and induced-neurons cell systems. We find that FBXO7(-/-) cells have no demonstrable defect in: (i) kinetics of pUb accumulation, (ii) pUb puncta on mitochondria by super-resolution imaging, (iii) recruitment of Parkin and autophagy machinery to damaged mitochondria, (iv) mitophagic flux, and (v) mitochondrial clearance as quantified by global proteomics. Moreover, global proteomics of neurogenesis in the absence of FBXO7 reveals no obvious alterations in mitochondria or other organelles. These results argue against a general role for FBXO7 in Parkin-dependent mitophagy and point to the need for additional studies to define how FBXO7 mutations promote parkinsonian-pyramidal syndrome.
引用
收藏
页数:26
相关论文
共 50 条
  • [1] Structure and Function of Fbxo7/PARK15 in Parkinson's Disease
    Randle, Suzanne J.
    Laman, Heike
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2017, 18 (07) : 715 - 724
  • [2] FBXO7 Mutations Causing Parkinsonian-Pyramidal Syndrome (PARK15) are Associated with Severely Decreased Levels of Fbxo7 Protein
    Zhao, T.
    Dekker, M. C.
    Montagna, P.
    Oostra, B. A.
    Bonifati, V.
    MOVEMENT DISORDERS, 2010, 25 : S726 - S726
  • [3] PINK1 Is Dispensable for Mitochondrial Recruitment of Parkin and Activation of Mitophagy in Cardiac Myocytes
    Kubli, Dieter A.
    Cortez, Melissa Q.
    Moyzis, Alexandra G.
    Najor, Rita H.
    Lee, Youngil
    Gustafsson, Asa B.
    PLOS ONE, 2015, 10 (06):
  • [4] Fbxo7 and Pink1 play a reciprocal role in regulating their protein levels
    Huang, Tianwen
    Fang, Lijun
    He, Raoli
    Weng, Huidan
    Chen, Xiaochun
    Ye, Qinyong
    Qu, Dianbo
    AGING-US, 2021, 13 (01): : 77 - 88
  • [5] Loss of Nuclear Activity of the FBXO7 Protein in Patients with Parkinsonian-Pyramidal Syndrome (PARK15)
    Zhao, Tianna
    De Graaff, Esther
    Breedveld, Guido J.
    Loda, Agnese
    Severijnen, Lies-Anne
    Wouters, Cokkie H.
    Verheijen, Frans W.
    Dekker, Marieke C. J.
    Montagna, Pasquale
    Willemsen, Rob
    Oostra, Ben A.
    Bonifati, Vincenzo
    PLOS ONE, 2011, 6 (02):
  • [6] Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice
    Vingill, Siv
    Brockelt, David
    Lancelin, Camille
    Tatenhorst, Lars
    Dontcheva, Guergana
    Preisinger, Christian
    Schwedhelm-Domeyer, Nicola
    Joseph, Sabitha
    Mitkovski, Miso
    Goebbels, Sandra
    Nave, Klaus-Armin
    Schulz, Joerg B.
    Marquardt, Till
    Lingor, Paul
    Stegmueller, Judith
    EMBO JOURNAL, 2016, 35 (18): : 2008 - 2025
  • [7] The lysosomal membrane protein LAMP-2 is dispensable for PINK1/Parkin-mediated mitophagy
    Liu, Xuemei
    Liao, Xinyi
    Rao, Xiyun
    Wang, Bin
    Zhang, Jun
    Xu, Ge
    Jiang, Xuejun
    Qin, Xia
    Chen, Chengzhi
    Zou, Zhen
    FEBS LETTERS, 2020, 594 (05) : 823 - 840
  • [8] FBXO7/ntc and USP30 antagonistically set the ubiquitination threshold for basal mitophagy and provide a target for Pink1 phosphorylation in vivo
    Sanchez-Martinez, Alvaro
    Martinez, Aitor
    Whitworth, Alexander
    PLOS BIOLOGY, 2023, 21 (08)
  • [9] Mutations of the VPS35 (PARK17) and FBXO7 (PARK15) genes associated with pathological finding of Lewy body pathology
    Mensikova, K.
    Tuckova, L.
    Vodicka, R.
    Kolarikova, K.
    Bartonikova, T.
    Ehrmann, J.
    Vrtel, R.
    Kanovsky, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 514 - 514
  • [10] Chemical inhibition of FBXO7 reduces inflammation and confers neuroprotection by stabilizing the mitochondrial kinase PINK1
    Liu, Yuan
    Lear, Travis B.
    Verma, Manish
    Wang, Kent Z. Q.
    Otero, P. Anthony
    McKelvey, Alison C.
    Dunn, Sarah R.
    Steer, Erin
    Bateman, Nicholas W.
    Wu, Christine
    Jiang, Yu
    Weathington, Nathaniel M.
    Rojas, Mauricio
    Chu, Charleen T.
    Chen, Bill B.
    Mallampalli, Rama K.
    JCI INSIGHT, 2020, 5 (11)